Isracann Biosciences Inc. (IPOT.CN) Research

Founded in 2010 and based in Vancouver, Canada, Isracann Biosciences Inc. focuses on the cultivation and distribution of medical cannabis. The company conducts its operations and develops its growing infrastructure within Israel, also serving the German market through product exports. Its current name, Isracann Biosciences Inc., was adopted in October 2019, succeeding its former identity as Atlas Blockchain Group Inc.

Market snapshot

Symbol
IPOT.CN
Price
$0.02
Day change
0.00%
Market cap
$2.6M
P/E ratio
-0.47x
52-week range
0.015-0.015
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Aion Therapeutic Inc. (AION.CN)
  • AREV Life Sciences Global Corp. (AREV.CN)
  • Acerus Pharmaceuticals Corporation (ASP.TO)
  • CBD Global Sciences Inc. (CBDN.CN)
  • Craftport Cannabis Corp. (CFT.CN)
  • Choom Holdings Inc. (CHOO.CN)
  • Flower One Holdings Inc. (FONE.CN)
  • ManifestSeven Holdings Corporation (MSVN.CN)

Open Isracann Biosciences Inc. (IPOT.CN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.